subscribe Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Subscribe now
Picture: BLOOMBERG/WALDO SWIEGERS
Picture: BLOOMBERG/WALDO SWIEGERS

Aspen’s disposal of its European thrombosis business has helped the firm to slash its annual net debt by more than 50%.

The debt reduction has allowed the pharmaceutical manufacturer to reinstate dividends at R2.62 after scrapping payouts before the pandemic.

Alishia Seckam spoke to CEO Stephen Saad for more detail.

Companies in this Story

subscribe Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Subscribe now

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.